Review Product Marketing Authorisation For Human Use "cetirizine Thinks».

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Cetirizina Pensa».

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-03-02&atto.codiceRedazionale=15A01397&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

Retrieved February 10, 2015 2015 # 229/V&A determines the authorized the following b. II. d. 1. and Review specification parameters and/or limits of the finished product Review outside the specification limits approved in respect of the medicine CETIRIZINE THINKS, in the forms and 037827021-10 # A.I.C. packs «mg/ml oral drops, solution 20 ml bottle: part of measure in graphic format Holder A.I. C : Think Pharma S.p.a. with registered office and tax domicile in via Rosellini Ippolito n. 12, 20124 Milan-Italy, (tax code # 02652831203).
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1 paragraph 5 of the April 14, 2014 # 371 Determines AIFA published in Official Gazette No 101 of May 3, 2014.
Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana.